Clinical Trials: Hemophilia

California

Duarte; City of Hope
An International, Randomized, Controlled Trial of Immune-Tolerance Induction

Duarte; City of Hope
Hemophilia Inhibitor Genetics Study

Duarte; City of Hope
Universal Data & Serum Specimen Collection System for Hemophilia

Duarte; City of Hope
Delineation of Causative Mutations in Hemophilia B

Duarte; City of Hope
Hemophilic Genotype, Inhibitors and Response to Immune Tolerance

Michigan

Detroit; Henry Ford Health System - Josephine Ford Cancer Center
Pain in the bleeding disorders community

New York

New York; Mount Sinai Medical Center
Advate Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate rAHF PFM): A Phase 4 Study Comparing Two Prophylactic Regimens in Subjects with Severe or Moderately Severe Hemophilia A [060201]

New York; Mount Sinai Medical Center
Advate Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate rAHF PFM): A Phase 4 Study Comparing Two Prophylactic Regimens in Subjects with Severe or Moderately Severe Hemophilia A [060201]


Back to Clinical Trials by Medical Areas

Research centers
specializing in
this illness area

Additional resources
in this illness area

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listing updated: May 13, 2008 at 3:06:31 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA